Initial Experience of Atrial Septostomy Treatment for Symptomatic
Nonobstructive Hypertrophic Cardiomyopathy: A Case Report
- tao an
, - Yuhui Zhang,
- Jian Zhang,
- Yi Mao
Yuhui Zhang
Fuwai Hospital State Key Laboratory of Cardiovascular Disease
Author ProfileJian Zhang
Fuwai Hospital State Key Laboratory of Cardiovascular Disease
Author ProfileYi Mao
Fuwai Hospital State Key Laboratory of Cardiovascular Disease
Author ProfileAbstract
Nonobstructive Hypertrophic Cardiomyopathy with preserved EF is a
well-known ejection fraction preserved heart failure and oral medical
therapy is the major treatment. Interatrial shunt devices have
preliminarily been shown to be safe and efficacious for the treatment of
HFpEF, their utilization in nonobstructive hypertrophic cardiomyopathy
patients has not been describe05 Apr 2022Submitted to Clinical Case Reports 07 Apr 2022Submission Checks Completed
07 Apr 2022Assigned to Editor
16 Apr 2022Reviewer(s) Assigned
24 May 2022Review(s) Completed, Editorial Evaluation Pending
26 May 2022Editorial Decision: Revise Minor
29 Jul 20221st Revision Received
01 Aug 2022Assigned to Editor
01 Aug 2022Submission Checks Completed
01 Aug 2022Review(s) Completed, Editorial Evaluation Pending
10 Aug 2022Reviewer(s) Assigned
05 Sep 2022Editorial Decision: Revise Minor
22 Oct 20222nd Revision Received
25 Oct 2022Submission Checks Completed
25 Oct 2022Assigned to Editor
25 Oct 2022Review(s) Completed, Editorial Evaluation Pending
23 Nov 2022Reviewer(s) Assigned
23 Jan 2023Editorial Decision: Revise Major
